Back to Results
First PageMeta Content
Eli Lilly and Company / Lung cancer / Lipoplatin / Pemetrexed / Carboplatin / Cisplatin / Non-small-cell lung carcinoma / Gemcitabine / Oxaliplatin / Chemistry / Alkylating antineoplastic agents / Ammine complexes


PUBLIC PRESS RELEASE OCTOBER[removed]Pres s Releas e
Add to Reading List

Document Date: 2012-06-19 05:55:21

Open Document

File Size: 1,65 MB

Share Result on Facebook

City

Athens / Silicon Valley / Palo Alto / /

Company

Regulon Inc. / EPO / /

Continent

Asia / /

Country

United States / /

Event

Patent Filing / FDA Phase / /

IndustryTerm

conventional imaging technologies / biopharmaceutical / /

MedicalCondition

Tumor / breast cancers / adenocarcinomas / non-squamous non-small cell lung cancer / cancer / tumors / disease / NSCLC / mainly representing adenocarcinomas / testicular cancer / small cell lung cancer / lung cancer / revolutionized cancer / largest cancer / Carcinomas / metastases / primary tumor / /

MedicalTreatment

hemodialysis / chemotherapy / /

Movie

Quality Of Life / /

Organization

European Union / /

Person

George Stathopoulos / Teni Boulikas / /

Position

President and CEO / /

Product

carboplatin / cisplatin / Alimta / paclitaxel / Lipoplatin / Lipoplatin™ / /

ProvinceOrState

California / /

Technology

chemotherapy / http / conventional imaging technologies / /

URL

www.springerlink.com/content / http /

SocialTag